| Company | 合同会社Dr. Shu Office Dr. Shu Office LLC |
|---|---|
| CEO | 田邊修一 薬剤師、博士（薬学） Shu Tanabe, Pharmacist, Ph.D. |
| Tasks | RAQA of IVD, CMC Consultant, Regulatory Consultation of Advertising Materials of Medical Products, Education, Japanese Foods Global Expansion & Hospital Business Consultation (Go) |
| Address | 静岡市清水区殿沢1-1-7-2、424-0912 日本 1-1-7-2 Tonosawa, Shizuoka, 424-0912 Japan |
合同会社Dr. Shu Office 代表
Shu Tanabe, Pharmacist (Japan), Ph.D.
静岡県立大学大学院薬学研究科博士課程修了。国際的トップ企業であるヤクルト、アステラス製薬、QIAGEN、ガルデルマ、エスティ ローダー カンパニーズにおいてリーダーシップを発揮してきました。
医薬品・体外診断用医薬品(IVD)・医療機器・化粧品分野における申請薬事、品質保証、規制戦略、CMCの科学そして戦略に精通し、グローバル企業と日本企業の双方の視点を理解しています。
Dr. Shu Officeの強みは、「現場を知る戦略家集団」であることです。
我々は科学、法規、経営学に基づいた実装可能な戦略を提案し、科学、法規、経営学に基づいた確実・着実な実務を提供いたします。
He earned his Ph.D. in Pharmaceutical Sciences from the Graduate School of Pharmaceutical Sciences, University of Shizuoka. He has held leadership positions at leading global companies, including Yakult, Astellas Pharma, QIAGEN, Galderma, and The Estée Lauder Companies. He has extensive expertise in regulatory affairs, quality assurance, regulatory strategy, and CMC science and strategy across pharmaceuticals, in vitro diagnostics (IVDs), medical devices, and cosmetics. His experience enables him to understand both global and Japanese business perspectives.
The strength of Dr. Shu Office is that we are strategists with real-world, hands-on experiences.
We develop practical and actionable strategies based on SCIENCE, REGULATION & ECONOMICS. We also provide reliable, step-by-step execution to turn these strategies into results.